【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 14
2 Introduction 15
2.1 Ovarian Cancer Overview 15
3 Products under Development 16
3.1 Ovarian Cancer – Pipeline Products by Stage of Development 16
3.2 Ovarian Cancer – Pipeline Products by Territory 17
3.3 Ovarian Cancer – Pipeline Products by Regulatory Path 18
3.4 Ovarian Cancer – Pipeline Products by Estimated Approval Date 19
3.5 Ovarian Cancer – Ongoing Clinical Trials 20
4 Ovarian Cancer – Pipeline Products under Development by Companies 21
4.1 Ovarian Cancer Companies – Pipeline Products by Stage of Development 21
4.2 Ovarian Cancer – Pipeline Products by Stage of Development 25
5 Ovarian Cancer Companies and Product Overview 29
5.1 A&G Pharmaceutical, Inc. Company Overview 29
5.1.1 A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.2 Abcodia Ltd. Company Overview 31
5.2.1 Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.3 Abnova Corporation Company Overview 32
5.3.1 Abnova Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Adaptive Biotechnologies Corporation Company Overview 34
5.4.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Almac Diagnostics Limited Company Overview 35
5.5.1 Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 AroCell AB Company Overview 36
5.6.1 AroCell AB Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Arrayit Diagnostics, Inc. Company Overview 37
5.7.1 Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.8 ArtemixRx Company Overview 39
5.8.1 ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 39
5.9 Aurelium BioPharma Inc. (Inactive) Company Overview 40
5.9.1 Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 Axela Inc. Company Overview 42
5.10.1 Axela Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Ayanda Biosystems S.A. Company Overview 43
5.11.1 Ayanda Biosystems S.A. Pipeline Products & Ongoing Clinical Trials Overview 43
5.12 Becton, Dickinson and Company Company Overview 44
5.12.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 44
5.13 Bioindustry Park Silvano Fumero S.p.A. Company Overview 46
5.13.1 Bioindustry Park Silvano Fumero S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 46
5.14 BioMark Diagnostics Inc. Company Overview 47
5.14.1 BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.15 Ceres Nanosciences, Inc. Company Overview 48
5.15.1 Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.16 Chronix Biomedical, Inc. Company Overview 50
5.16.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.17 Clarient, Inc. Company Overview 52
5.17.1 Clarient, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.18 ClavGen Therapeutics LLC Company Overview 53
5.18.1 ClavGen Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 53
5.19 Cleveland Diagnostics Inc. Company Overview 54
5.19.1 Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.20 Clovis Oncology, Inc. Company Overview 55
5.20.1 Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.21 Cornell University Company Overview 57
5.21.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 57
5.22 Courtagen Life Sciences, Inc. Company Overview 58
5.22.1 Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.23 CS-Keys, Inc. Company Overview 59
5.23.1 CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.24 Dako A/S Company Overview 60
5.24.1 Dako A/S Pipeline Products & Ongoing Clinical Trials Overview 60
5.25 Dana-Farber Cancer Institute, Inc. Company Overview 61
5.25.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.26 diaDexus, Inc. Company Overview 62
5.26.1 diaDexus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.27 Eventus Diagnostics, Inc. Company Overview 67
5.27.1 Eventus Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.28 Exiqon A/S Company Overview 68
5.28.1 Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview 68
5.29 Exosomics Siena SpA Company Overview 70
5.29.1 Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 70
5.30 Foundation Medicine, Inc. Company Overview 71
5.30.1 Foundation Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.31 Ganymed Pharmaceuticals AG Company Overview 73
5.31.1 Ganymed Pharmaceuticals AG Pipeline Products & Ongoing Clinical Trials Overview 73
5.32 GeneNews Limited Company Overview 74
5.32.1 GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview 74
5.33 Georgia Institute of Technology Company Overview 76
5.33.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 GlycoZym Company Overview 78
5.34.1 GlycoZym Pipeline Products & Ongoing Clinical Trials Overview 78
5.35 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 79
5.35.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.36 Ikonisys, Inc. Company Overview 80
5.36.1 Ikonisys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.37 Inanovate (UK) Ltd. Company Overview 81
5.37.1 Inanovate (UK) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
5.38 IncellDx, Inc. Company Overview 82
5.38.1 IncellDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.39 Innovative Health Diagnostics Company Overview 83
5.39.1 Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 83
5.40 Institut National de la Sante et de la Recherche Medicale Company Overview 84
5.40.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 84
5.41 InterGenetics Incorporated Company Overview 85
5.41.1 InterGenetics Incorporated Pipeline Products & Ongoing Clinical Trials Overview 85
5.42 IV Diagnostics, Inc. Company Overview 86
5.42.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
5.43 KIYATEC Inc. Company Overview 87
5.43.1 KIYATEC Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.44 Lab Discoveries Ltd. Company Overview 88
5.44.1 Lab Discoveries Ltd. Pipeline Products & Ongoing Clinical Trials Overview 88
5.45 Laboratorios SALVAT S.A. Company Overview 89
5.45.1 Laboratorios SALVAT S.A. Pipeline Products & Ongoing Clinical Trials Overview 89
5.46 Laboratory Corporation of America Holdings Company Overview 90
5.46.1 Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 90
5.47 Louisville Bioscience, Inc. Company Overview 92
5.47.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 92
5.48 MabCure Inc. Company Overview 93
5.48.1 MabCure Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.49 Manalto Limited Company Overview 95
5.49.1 Manalto Limited Pipeline Products & Ongoing Clinical Trials Overview 95
5.50 MDNA Life Sciences, Inc. Company Overview 100
5.50.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
5.51 MDxHealth SA Company Overview 101
5.51.1 MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 101
5.52 Metabolon, Inc. Company Overview 103
5.52.1 Metabolon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.53 Milagen, Inc. Company Overview 104
5.53.1 Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.54 Myriad Genetics, Inc. Company Overview 105
5.54.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.55 Nanosphere, Inc. Company Overview 107
5.55.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.56 National University of Singapore Company Overview 109
5.56.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 109
5.57 Neogenix Oncology, Inc. Company Overview 110
5.57.1 Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.58 Novel Bio-spectrum Technologies, Inc. Company Overview 111
5.58.1 Novel Bio-spectrum Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.59 NuCana BioMed Limited Company Overview 112
5.59.1 NuCana BioMed Limited Pipeline Products & Ongoing Clinical Trials Overview 112
5.60 Oncgnostics GmbH Company Overview 113
5.60.1 Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 113
5.61 Orion Genomics LLC Company Overview 114
5.61.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 114
5.62 Oryzon Genomics S.A. Company Overview 115
5.62.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 115
5.63 OTraces Inc. Company Overview 116
5.63.1 OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.64 OvaGene Oncology Inc. Company Overview 117
5.64.1 OvaGene Oncology Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.65 PeriRx LLC Company Overview 118
5.65.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 118
5.66 Pronota NV Company Overview 119
5.66.1 Pronota NV Pipeline Products & Ongoing Clinical Trials Overview 119
5.67 Protagen AG Company Overview 120
5.67.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 120
5.68 Proteomika Company Overview 121
5.68.1 Proteomika Pipeline Products & Ongoing Clinical Trials Overview 121
5.69 Provista Diagnostics Inc. Company Overview 122
5.69.1 Provista Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 122
5.70 RCP Diagnostics, LLC (Inactive) Company Overview 123
5.70.1 RCP Diagnostics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 123
5.71 RiboMed Biotechnologies, Inc. Company Overview 124
5.71.1 RiboMed Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.72 Rice University Company Overview 125
5.72.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 125
5.73 Roche Diagnostics International Ltd. Company Overview 127
5.73.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 127
5.74 Rosetta Genomics, Ltd. Company Overview 129
5.74.1 Rosetta Genomics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 129
5.75 Rush University Medical Center Company Overview 131
5.75.1 Rush University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 131
5.76 SomaLogic, Inc. Company Overview 132
5.76.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 132
5.77 Soricimed Biopharma Inc. Company Overview 133
5.77.1 Soricimed Biopharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.78 Stage I Diagnostics, Inc. Company Overview 135
5.78.1 Stage I Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.79 SurExam Life Science & Technology Co. Company Overview 136
5.79.1 SurExam Life Science & Technology Co. Pipeline Products & Ongoing Clinical Trials Overview 136
5.80 Target Discovery, Inc. Company Overview 137
5.80.1 Target Discovery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.81 Teva Pharmaceutical Industries Limited Company Overview 138
5.81.1 Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview 138
5.82 The Johns Hopkins University Company Overview 140
5.82.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 140
5.83 The University of Adelaide Company Overview 142
5.83.1 The University of Adelaide Pipeline Products & Ongoing Clinical Trials Overview 142
5.84 The University of Texas M. D. Anderson Cancer Center Company Overview 143
5.84.1 The University of Texas M. D. Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 143
5.85 Todos Medical Company Overview 144
5.85.1 Todos Medical Pipeline Products & Ongoing Clinical Trials Overview 144
5.86 Transbiomed, SL Company Overview 145
5.86.1 Transbiomed, SL Pipeline Products & Ongoing Clinical Trials Overview 145
5.87 Universite de Montreal Company Overview 146
5.87.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 146
5.88 University of South Florida Company Overview 148
5.88.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 148
5.89 US Biomarkers, Inc. Company Overview 150
5.89.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.90 Vermillion, Inc. Company Overview 151
5.90.1 Vermillion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.91 Vitatex Inc. Company Overview 154
5.91.1 Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview 154
5.92 Vitruvian Biomedical, Inc. Company Overview 157
5.92.1 Vitruvian Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.93 Yale University Company Overview 158
5.93.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 158
6 Ovarian Cancer- Recent Developments 159
7 Appendix 171
7.1 Methodology 171
7.2 About GlobalData 173
7.3 Contact Us 174
7.4 Disclaimer 174
【レポート販売概要】
■ タイトル：世界における卵巣がん検査製品のパイプライン動向2015■ 英文：Ovarian Cancer - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0074EPD
■ 調査対象地域：グローバル
- リファビッシュ（再生）医療機器の世界市場The global refurbished medical equipment market is estimated to grow at a CAGR of 12.5% from 2014 to 2019. North America held the largest share of the refurbished medical equipment market in 2014. However, the Asia-Pacific region is poised to grow at the highest CAGR of 13.7% in the next five years. Factors such as increasing privatization of the healthcare sector, growing number of hospitals and …
- Synthes, Inc.：市場シェア分析Synthes, Inc. Market Share Analysis Summary GlobalData’s new report, “Synthes, Inc. Market Share Analysis” provides in-depth information on Synthes, Inc.’s market position in the different medical equipment markets it operates in. The report provides Synthes, Inc. market share information in five key market categories – Cranio Maxillofacial Fixation (CMF), Orthobiologics, Orthopedic Tools, Spinal …
- 世界のフレーバー（風味）及びフレグランス（香料）市場2014：主要企業の戦略的分析This new 550-page report from Venture Planning Group contains 65 tables, and presents a thought-provoking analysis of the performance, capabilities, goals and strategies of the major competitors in the worldwide flavor and fragrance market. The study is designed to provide the flavor and fragrance industry executives with strategically significant competitor information, analysis, and insight …
- Hypoxemia：グローバル臨床試験レビューH1, 2013Hypoxemia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Hypoxemia Global Clinical Trials Review, H1, 2013" provides data on the Hypoxemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypoxemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- 菓子類加工機械の世界市場予測（～2023年）“Confectionery processing equipment market is projected to grow at a CAGR of 6.90%”The confectionery processing equipment market is estimated to be valued at USD 4.69 billion in 2018, and is projected to reach USD 6.55 billion by 2023, at a CAGR of 6.90% from 2018. Factors such as growth of the retail industry have driven the growth of the confectionery processing equipment market. Growth in deman …
- 2014年戦略提言：フランスの微生物検査市場Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300. “2014 Strategies for the French Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews current and emerging assays; …
- 消費者向け書籍出版の世界市場2016-2020Consumer book publishing refers to publishing of books that are meant for casual reading. Fiction and non-fiction are the two major types of books under consumer book publishing segment. Consumer book publishing account for almost half of the overall book publishing market.Technavio’s analysts forecast the global consumer book publishing market to grow at a CAGR of 0.98% during the period 2016-202 …
- 天然・有機パーソナルケア製品の世界市場2019-2023About this market Increasing awareness of natural and organic personal care products to drive growth in the market. Natural and organic personal care products are gaining popularity due to increasing consumer preference toward natural cosmetics and personal care products around the world, as they have been a vital part of consumer's lives. People are becoming aware of personal health and personal …
- 世界の気象・天気予報システム/装置市場予測と分析（2014 – 2020）This report discusses market opportunities in the meteorological and weather forecasting systems market. These systems have huge potential given their applications in the aviation, marine, and military segments.Weather forecasting involves prediction of atmospheric conditions at a specific time for the given location. Such forecasting systems require a combination of computer models, observations, …
- 多連装ロケットシステム（MLRS）の世界市場2016-2020About MLRS MLRS is an adaptable precision-approach weapon system that complements traditional cannon artillery fires. The system delivers a large volume of firepower along with shoot-and-scoot capability in a short duration against perilous, time-sensitive targets. These targets include mechanized units, air defense systems, enemy artillery, and personnel. Technavio’s analysts forecast the global …
- 民間ヘリコプタMRO（メンテナンス、修理、オーバーホール）の世界市場About Civil Helicopter MRO Helicopters play a key role in remote area connectivity, intra-city movement, law enforcement, disaster relief, search and rescue, and emergency medical evacuation. Aircraft maintenance, repair, and overhaul (MRO) has become an essential component to ensure a fleet's proper maintenance, airworthiness, and passenger safety. MRO companies perform functions such as repairs, …
- プロパントの世界市場予測（～2022年）The proppant market size is projected to reach USD 9.87 Billion by 2022, at a CAGR of 6.9% between 2017 and 2022. Proppant products find usage in hydraulic fracturing of unconventional gasses, such as shale gas, tight gas, and coal bed methane. Rising use of proppant in the oil and gas industry have led to an increased demand for proppant, globally. Proppant is majorly classified into three types, …
- マンガン採鉱の世界市場2016-2020About Manganese Mining Manganese is widely used in steel production for desulfuration and deoxidization. It enhances tensile strength, wear resistance, weldability, and hardness of steel. In 2015, out of the total manganese alloys produced, 90.06% was used in the production of steel. It is also used with aluminum, copper, and other elements to make different alloys. Manganese is found as braunite, …
- 電気自動車充電設備の世界市場2014-2018About Electric Vehicle Charger An EVC, technically known as EVSE, is an electrical device that consists of a box with a cord and a plug. It is used to connect the electric power source, such as a wall socket, to an EV and recharge the batteries installed in the EV. A majority of EV manufacturers provide and install an EVSE along with the EV. EV owners often purchase an additional EVC for installat …
- ラテンアメリカの生命保険市場2016-2020About the Life Insurance Market in Latin America Life insurance is a major tool in basic estate planning. The compensation received as part of life insurance claim is tax free and often exceeds the premiums paid. In the current market scenario, there are many top life insurance vendors offering a huge number of product portfolios. With this scenario in place, the demand for life insurance policies …
